Carl W. Bazil, MD, PhD, is an Associate Professor of Clinical Neurology, College of Physicians and Surgeons at Columbia University. He is the Director of Clinical Anticonvulsant Drug Trials and of the Neurology Division of the Columbia Comprehensive Sleep Center at the Neurological Institute in New York City.

Dr. Bazil received his undergraduate degree from the Massachusetts Institute of Technology, and his PhD (pharmacology) and medical degree from Emory University. He was a Neurology Resident at New York University, and served as Chief Resident and Instructor there. He was a Clinical Fellow in Epilepsy/EEG at the Neurological Institute of Columbia Presbyterian Medical Center, Columbia University. He is board certified in Neurology, Clinical Neurophysiology, and Sleep Medicine.

Dr. Bazil’s research interests are primarily in the interaction between sleep, sleep disorders, and epilepsy, as well as in finding new treatments for epilepsy. He is currently the Principal Investigator of a study of a new drug for epilepsy, and of a device trial for refractory epilepsy that uses deep brain stimulation. He has also received grants for sleep studies for epileptic patients from Columbia University and the Epilepsy Foundation of America; and has been an Investigator for studies involving the safety, tolerability and efficacy of a variety of epilepsy drugs.

Active in various organizations in his field of study, Dr. Bazil is a Board Member of the American Clinical Neurophysiology Society. He has been a Contributing Editor for Epilepsy Currents, and is a Member of the Editorial Board of Epilepsy Research and Epilepsy.com. He is also an Ad Hoc Reviewer for Epilepsia, European Journal of Neurology, Physiology and Behavior, Annals of Neurology, Archives of Neurology, Sleep, Brain, Clinical Therapeutics, and Neuroscience Letters.

Dr. Bazil has published over 60 articles in professional journals, has written a book for patients on epilepsy, has edited a book on sleep and epilepsy, and has contributed 14 chapters to various texts in his field. Dr. Bazil has been an invited lecturer at numerous national and international meetings mainly on the topic of sleep and epilepsy.

William E. Braunlich is Senior Vice President, Development, of the Epilepsy Therapy Development Project, a charitable organization dedicated to advancing new therapies for people living with epilepsy. Mr. Braunlich recently retired, after 15 years, as President of Volt Telecommunications Group, Inc., a global, full service provider of turnkey telecommunications services. Earlier, Mr. Braunlich spent 30 years in the Bell System, in various operating telephone companies and AT&T, in senior management positions.

Mr. Braunlich is immediate past chair of the Epilepsy Foundation, Treasurer of the Epilepsy Foundation – Massachusetts and Rhode Island and is active in numerous charitable and community organizations.

Mr. Braunlich received his B.A. from Hamilton College in Clinton, New York, and his MBA from New York University where he majored in finance and marketing.

Mr. Braunlich served in the United States Naval Reserve for 23 years on active duty and active reserve duty in Anti-Submarine Warfare and retired as a commander.

Carol S. Camfield is Professor of Pediatrics at the Dalhousie University Medical School in Halifax, Nova Scotia where she is in the Division of Child Neurology. She received her BS, MD and pediatric training from the University of Michigan and was a Robert Wood Johnson Scholar at McGill University in epidemiology before moving with her family to Halifax. There she and her husband, Peter, created and followed a large population-based cohort of children with epilepsy over the past 20 years. Many publications have followed from the inception of this group which describe the natural history of childhood epilepsy, management and treatment and long-term social outcomes of these children. Carol is also interested in quality of life issues and the impact and management of pain in children with severe cognitive impairments.

Both the The Clinical Investigator Award of American Epilepsy Society/Milken Family Foundation and the Wilder Penfield Award of the Canadian League Against Epilepsy have been awarded to the Camfields. Carol has authored more than 200 peer reviewed publications, 35 book chapters and given numerous presentations. She serves on the Editorial Boards of Pediatric Neurology, Journal of Child Neurology and Epilepsy & Behavior and is a reviewer for many journals. She was one of the founding members of the Epilepsy Association of Nova Scotia and has been on its BOD for the past 25 years with a special interest in education. She is active on several Committees of the ILAE and American Epilepsy Association and is a past board of director of Epilepsy Canada.

James Cloyd, PharmD, is Professor of Pharmacy, Lawrence C. Weaver Endowed Chair for Orphan Drug Development and Director of the Center for Orphan Drug Research. He also serves as Co-Director of the Epilepsy Research and Education Program at the University of Minnesota College of Pharmacy. He received his BS from Purdue University in 1971 and his PharmD from the University of Kentucky in 1976 where he concurrently completed a 3 year hospital pharmacy residency. From 1985-1986, he studied clinical pharmacokinetics during a fellowship at the University of Washington. Dr. Cloyd has been funded by the National Institutes of Health, foundations, and the pharmaceutical industry to support his research, which focuses on orphan drug development and antiepileptic drug clinical pharmacology. He has published over 100 articles, book chapters, and monographs and advised 18 graduate students and post-doctoral fellows. Dr. Cloyd is a recipient of the Research Achievement Award from the American Pharmacists Association and the Weaver Medal for Distinguished Contributions to Pharmacy Education and Research given by the University of Minnesota College of Pharmacy. He is a Fellow of the American Pharmacists Association and the American College of Clinical Pharmacy. He lectures to pharmacy students, neurology residents, and health professionals on neurotherapeutics and the application of clinical pharmacology principles to AED therapy. His teaching has been recognized by the University of Minnesota, which has designated him a Morse Alumni Distinguished Teaching Professor and a member of the Academy of Distinguished Teachers.

Joyce A. Cramer is President of the Epilepsy Therapy Development Project (ETDP), a non-profit organization advancing new therapies for people living with epilepsy , and Associate Research Scientist at Yale University School of Medicine, New Haven, CT. Her academic career includes several decades of work in epilepsy and clinical trials to evaluate treatment outcomes. She developed methods for the evaluation of antiepileptic drug efficacy and adverse effects, study design and management, and enhancement of medication compliance, as well as instruments to assess quality of life, treatment satisfaction, and other patient-reported outcomes.

Her publications include 5 books, more than 180 peer-reviewed manuscripts, 35 book chapters, and numerous abstracts, covering topics in medicine, neurology, psychiatry, research design, medication compliance & persistence, quality of life, and other patient-reported outcomes. The books are titled: Quantitative Assessment in Epilepsy Care, Quality of Life and Pharmacoeconomics: An Introduction, Alcohol and Seizures, Patient Compliance in Medical Practice and Clinical Trials, Patient Recruitment in Clinical Trials.

Joyce has been a member of the ETDP Governing Board since its inception. Her professional activities have included positions as Treasurer of the American Epilepsy Society (AES), AES Board of Directors, Chair of the Board of Trustees of the AES-William G. Lennox Fund. She also has served on the Board of Directors of the Society for Clinical Trials and the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).

She currently serves on the Editorial Boards of Epilepsy & Behavior, Acta Neurologica Scandinavica, and Management Advisory Board for Value in Health. She has served on the Editorial Board for Epilepsia, chaired the ILAE Commission on Outcome Measurement, and the ISPOR section on Medication Compliance. She was Associate Editor of epilepsy.com and professionals.epilepsy.com, website resources for patients, families, and healthcare providers.

She has received the Ambassador Award from the International League Against Epilepsy (ILAE) and the AES Service Award, as well as the International Research Promotion Council/World Scientist Forum Award: Eminent Scientist of the Year, and was twice awarded the ISPOR Distinguished Service Award.

Orrin Devinsky is Professor of Neurology, Neurosurgery, and Psychiatry at NYU School of Medicine. He directs the NYU and Mount Sinai Comprehensive Epilepsy Centers, the Staten Island University Hospital Comprehensive Epilepsy Center, and the Saint Barnabas Institute of Neurology and Neurosurgery (INN). He received his B.S. and M.S. from Yale University, M.D. from Harvard Medical School and interned at Boston’s Beth Israel Hospital. He completed neurology training at the New York Hospital-Cornell Medical Center and his epilepsy fellowship at the NIH.

His epilepsy research interests include: quality-of-life, cognitive and behavioral issues in epilepsy, surgical therapy, and new medications. He has published widely in epilepsy and behavioral neurology, with more than 200 articles and chapters and more than 15 books. He has chaired several committees of the American Epilepsy Society and has served as a Board member. He is active on the national boards of both the American Academy of Neurology and the Epilepsy Foundation. He is the Co-Editor of epilepsy.com, Epilepsy and Behavior, and Reviews in Neurological Diseases. Furthermore he is on the Editorial Board of several journals, and serves as a reviewer for many journals.

Dr. William R. Garnett received his Bachelor of Science in Pharmacy from the Medical College of Virginia/Virginia Commonwealth University in 1969 and his Doctor of Pharmacy degree from the Philadelphia College of Pharmacy and Science in 1973. Dr. Garnett joined the faculty at the University of North Carolina in 1973 and taught there from 1973 to 1976. While at UNC, Dr. Garnett learned to appreciate good basketball and still bleeds "Carolina Blue" during basketball season. In 1976 Dr. Garnett moved to the Virginia Commonwealth University/Medical College of Virginia where he is currently Professor of Pharmacy and Neurology.

Dr. Garnett has been actively involved in clinical epilepsy research for over 25 years. He has been involved in the evaluation of new antiepileptic drugs, the assessment of new formulations of antiepileptic drugs, the evaluation of drug-drug interactions with antiepileptic drugs, the assessment of side effects with antiepileptic drugs, the pharmacoeconomics of epilepsy care, and determination of quality of life in patients with epilepsy.

Dr. Garnett has published and presented widely in the area of epilepsy and antiepileptic drug therapy. He has published over 155 peer reviewed articles and 55 book chapters. His publications in the area of epilepsy include chapters in Managing Epilepsy and Co-Existing Disorders, Antiepileptic Drugs 5th edition, Pharmacotherapy: A Pathophysiologic Approach,Pediatric Epilepsy: Diagnosis and Therapy, Applied Pharmacokinetics, and Clinical Pharmacokinetics. His articles have appeared in Epilepsia, Neurology, Epilepsy Research, Clinical Therapeutics, Current Medical Research and Opinion, etc . He has made more than 1200 presentations at local, state, and national meetings. He is a Senior Editor for Long-Term Care Interface.

Dr. Garnett has been actively involved in a number of professional organizations as an officer, committee chairperson, and committee member. He is a fellow of the American College of Clinical Pharmacy. He is the 1996 recipient of the ACCP Education Award. In the fall of 1997 he was an invited by the Ministry of Health in the Republic of Singapore to be a visiting lecturer and clinical specialist.

Patricia Gibson is an Assistant Professor in the Division of Neurology at Wake Forest University School of Medicine. She received a BS in Psychology and Sociology from Radford University, followed by a Masters in Social Work from the University of Tennessee. Ms. Gibson is Associate Director of the Comprehensive Epilepsy Center at Wake Forest, where she provides individual, group and family counseling and is actively involved in medical student, nursing and patient education. She also serves as Director of the Epilepsy Information Service, a nationwide telephone information line for patients and their family members. Ms. Gibson has organized and conducted numerous regional as well as national and international conferences on epilepsy, including an annual conference at the American Epilepsy Society meeting titled Advances in the Management of Epilepsy and the Epilepsy Clinic and an annual Pediatric Epilepsy Symposium in the Southeast. She set up the Epilepsy Medication Fund for the state of North Carolina in 1987 and heads three major fundraisers for this fund. She is past President of the Epilepsy Foundation of North Carolina and serves on the Professional Advisory Board of this organization. She also serves on the Professional Advisory Board of the Tuberous Sclerosis Alliance and previously on the professional advisory board of C.U.R.E. (Citizens United for Research in Epilepsy).

Cynthia L. Harden, MD is an associate professor of neurology and neuroscience at the Weill Medical College of Cornell University in New York City. Affiliated with the Comprehensive Epilepsy Center at this institution for 12 years, Dr Harden is also an associate attending in neurology.

Dr Harden has lectured and conducted continuing medical education courses on a diverse list of epilepsy-related issues—including women’s and children’s concerns, the uses of new antiepileptic drugs, the effect of newer antiseizure treatments on sexual function, and new avenues for treating brain disease—to such groups as the American Academy of Neurology, the American Psychiatric Association, and the New York Academy of Medicine. A member of several professional societies, including the American Epilepsy Society and the American Academy of Neurology, Dr Harden serves as an officer in the epilepsy section of the Academy and is a member of its Therapeutics and Technology Assessment Subcommittee. Dr Harden’s research interests include assessing the effects of hormonal changes on epilepsy. For instance, in a study where Andrew Herzog, MD, MSc, is principal investigator, which is supported by the National Institute of Neurological Disorders and Stroke, she is exploring the effect of progesterone treatment versus placebo in women with epilepsy. Under a similar grant, Dr Harden was principal investigator in another study where she assessed hormone replacement therapy in menopausal women. Her privately funded research includes investigating the effects of add-on anastrozole in men with epilepsy. Dr Harden has also examined mood and anxiety disorders in people with epilepsy in response to various treatments and psychogenic pseudoseizures.

Dr Harden is an ad hoc reviewer for Neurology and Epilepsy Research, among other journals. She has also authored or collaborated on nearly a score of book chapters and more than 35 articles for peer-reviewed journals, such as Epilepsia, Pediatric Neurology, the Journal of Epilepsy, and the Journal of Neuroscience.

After earning her medical degree at the University of Wisconsin Medical School in Madison, Dr Harden served her internship and a year’s residency in internal medicine at St. Luke’s Hospital in New York City. She stayed in New York City to complete her residency training in neurology at Mount Sinai Hospital and a fellowship in clinical neurophysiology at Albert Einstein College of Medicine.

Bruce Hermann is Professor and Director of the Matthews Neuropsychology Section in the Department of Neurology at the University of Wisconsin-Madison.He currently serves as Chair of the Professional Advisory Board of the Epilepsy Foundation. His research interests include: the neuropsychological and behavioral complications of the epilepsies in children and adults, cognitive and quality of life outcomes following epilepsy surgery, and the relationship of memory and cognitive problems with various neuroimaging techniques.

Gregory L. Holmes, MD, is Professor of Neurology and Pediatrics at the Dartmouth Medical School in Hanover, New Hampshire. He is also Section Chief of Neurology at the Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire.

Dr. Holmes received his undergraduate degree from Washington and Lee University in Lexington, Virginia. He attained his medical degree at the University of Virginia Medical School in Charlottesville. He completed a residency and internship in Pediatrics at Yale University Medical Center in New Haven, Connecticut as well as in Neurology at the University of Virginia Medical School. He was also a visiting research scientist at the Institut National de la Santé de la Recherche Medicale in Paris, France.

Dr. Holmes is active in many professional societies, most notably the American Epilepsy Society (AES), which he is currently President of. Dr. Holmes is on the editorial boards for eight publications, including Clinical Neuropharmacology and Epilepsy Research, and is an ad-hoc reviewer for forty publications. He is a distinguished researcher, and has authored or co-authored over 200 peer reviewed articles, nearly one hundred review articles, and over 100 other book chapters, reviews and editorials.

Dr. Andres M. Kanner is a senior attending physician in the department of Neurological Sciences at Rush University Medical Center in Chicago, where he has also been director of the Laboratory of Electroencephalography and Video-EEG-Telemetry since 1991, when he joined the staff at the Rush Epilepsy Center. He also holds the positions of Associate Director of the Section of Epilepsy and of the Rush Epilepsy Center. He is also Professor of Neurological Sciences and Psychiatry at Rush Medical College.

Dr. Kanner was born and raised in Mexico City and received his MD (cum laude) from the Faculty of Medicine of the National Autonomous University of Mexico in Mexico City. He came to the United States in 1977 and completed a residency in Psychiatry at the Long-Island Jewish Hillside Medical Center in New Hyde Park, New York. In addition, Dr. Kanner completed a research fellowship in Child Psychiatry, sponsored by the National Institute of Mental Health, at the College of Physicians and Surgeons of Columbia University in New York City. It was during his training in psychiatry that Dr. Kanner became interested in epilepsy and went on to complete a residency in neurology at the Department of Neurology of Mount Sinai Medical Center in New York City. He completed his training with a fellowship in epilepsy and clinical neurophysiology at the Cleveland Clinic Foundation in Cleveland, Ohio. Dr. Kanner is triple boarded in neurology, psychiatry and clinical neurophysiology.

Dr Kanner has long-standing research interests in the areas of pharmacology of epilepsy, psychiatric aspects of epilepsy and surgical treatment of temporal lobe epilepsy. He has authored or coauthored over 60 research publications, over 20 invited review articles and over 30 book chapters and has co-edited four textbooks. Dr Kanner is a regular reviewer for several professional journals of neurology and psychaitry, including Neurology, Epilepsy & Behavior and Epilepsia. He is also an ad hoc reviewer for a number of other journals, an editorial board member for Epilepsy & Behavior, and a contributing editor for Epilepsy Currents.

Dr Kanner is a member of the American Epilepsy Society (AES), the American Academy of Neurology and the International Neuropsychiatric Association. He currently serves as chair of the practice guidelines committee of the American Epilepsy Society; he is serves in the Subcommittee of Education for Non-Neurologists of the American Academy of Neurology and is Chair of the Practice Committee of the Epilepsy Section of the American Academy of Neurology.

Dr. Eric Kossoff is an Assistant Professor of Neurology and Pediatrics and a member of The John M. Freeman Pediatric Epilepsy Center, as well as the Division of Pediatric Neurology. His clinical practice specializes in the diagnosis and treatment of childhood seizures and epilepsy, especially approaches other than medications (e.g. diet, neurostimulation (VNS and NeuroPace), and surgery). Dr. Kossoff's clinical and research interests include the ketogenic diet, Atkins diet (for both children and adults), VNS, infantile spasms, hemispherectomy, migraine headaches (and their interaction with epilepsy), and Sturge-Weber syndrome. Dr. Kossoff is also the Associate Director of the Pediatric Neurology Residency Program at Johns Hopkins Hospital. He is a coauthor of Treatment of Pediatric Neurologic Disorders and the upcoming 4th edition of The Ketogenic Diet with Dr. John Freeman.

Ruben Kuzniecky is Professor of Neurology, at NYU School of Medicine. He Co-directs the NYU Comprehensive Epilepsy Centers, and is Director of research at the NYU Epilepsy Center. He received his M.D. from Buenos Aires University in Argentina, followed by internship in Panama. He completed Medicine and Neurology training at the Montreal Neurological Institute, McGill University and his epilepsy fellowship at the MNI. He became Director of the UAB Epilepsy Center in 1995 and directed the Center until 2003 when he was recruited to NYU. Dr. Kuzniecky served as visiting professor in Radiology and Physics at the University College of London, UK in 1997-1998.

His epilepsy research interests include: Imaging of epilepsy in particular MRI, MRS and MEG. He is also internationally recognized for his research in malformations of brain development and epilepsy. He has published widely in imaging, epilepsy, with more than 200 articles and chapters and is the author of 2 books and one monograph. He has chaired several committees of the American Epilepsy Society and served as a Board member and Treasurer. Dr Kuzniecky is a regular reviewer for several professional journals of neurology and epilepsy and he is in the editorial board for Epilepsy & Behavior, RIND, EpilepsyHypertex, etc. He serves as CME Chair for the SEEEG Society.

Dr Kuzniecky has received multiple grants for his research from the NIH, Private foundations, AES, EFA and the Wellcome Fund and he is Co-PI of the Epilepsy Phenome/genome Project.

Warren B. Lammert is Chairman and Co-Founder of the Epilepsy Therapy Development Project and Epilepsy.com. Mr. Lammert serves on the board of directors of the Epilepsy Foundation and of FACES (Finding a Cure for Epilepsy and Seizures) at New York University.

Mr. Lammert is Founder, Principal and Chief Investment Officer of Granite Point Capital formed in January 2004 and has more than 18 years of investment industry experience. Prior to the formation of Granite Point Capital, he spent 14 years at Janus serving in several investment and senior management roles including most recently, Portfolio Manager of the Janus Mercury Fund from its inception in 1993 until March 2003. From July 1984 until joining Janus in 1987, Mr. Lammert served as Research Associate and then Associate Analyst at Fred Alger Management.

Mr. Lammert received his B.A. in Economics from Yale University and graduated with Distinction from the London School of Economics with a M.Sc. in Economic History. He serves on the board of directors of Village Ventures and has also earned the right to use the Chartered Financial Analyst designation.

Dr Mattson was born and raised in Connecticut, attended and received a BS degree from Yale University followed by his M.D. from Boston University. He did his neurology residency and a clinical neurophysiology fellowship at the Mayo Clinic. Following his formal training Dr Mattson spent five years with the USAF in San Antonio. During this time he and his colleagues did the initial studies on the effect of sleep deprivation on the occurrence of epileptic seizures and as an activating technique in EEG.
After returning to Yale on the faculty at the Medical School in the late 1960’s he focused on development of the Yale/VA Epilepsy Center and has been active in this field since that time. Initially efforts were directed to developing one of the first Intensive Monitoring Units. The Unit evaluated diagnostic problems and increasingly focused on intractable epilepsy and intracranial recording for possible epilepsy surgery.

His special area of interest increasingly turned toward antiepileptic drug therapy. He directed the two largest multi-center (VA Coop) studies that defined the effectiveness and adverse effects of the standard antiepileptic drugs. He continues to be active in development and evaluation the new AEDs.

For the past decade and a half Dr. Mattson directed the Yale/NIH Program Project that has studied both clinical and basic aspects of the role of GABA in the pathophysiology and treatment of epilepsy using microdialysis and nuclear magnetic resonance spectroscopy in patients on various antiepileptic drugs. He has authored or co-authored more than 200 papers, most in the field of epilepsy and is co-editor of a number of books including the standard reference, Antiepileptic Drugs.

Dr Mattson chaired the course on Clinical Epilepsy at the AAN for several years .In 1997 he became Chair of the Therapeutic Strategies Commissionof the International League Against Epilepsy, and continues to be especially active in development of the AED Guidelines for selection of therapy.

Dr Mattson has been the President of the American Epilepsy Society. He has been recognized with a number of prizes and awards including The William Lennox Award of the American Epilepsy Society, the Novartis/ILAE Epileptology Prize, The Hans Berger Award, The Clinical Investigator Award of American Epilepsy Society/Milken Family Foundation, the Hans Berger Distinguished Scholar Award and Who’s Who in the World.

In addition Dr Mattson has been active in education and was former director of the Yale Neurology Residency Program and the Director of the Medical Student Clinical Neuroscience Education at Yale Medical School. He has also been a member of the Yale Medical School Admissions and Faculty Promotions Committees.
Although made Professor Emeritus in 2003, Dr Mattson continues an active research, educational and patient care role as Senior Research Scientist.

Dr. Meador is presently the Melvin Greer Professor of Neurology at the University of Florida, where he serves as Director of Epilepsy Program and Director of Clinical Alzheimer Program. Dr. Meador graduated from Georgia Institute of Technology in Applied Biology and received his MD from Medical College of Georgia. After an internship at University of Virginia and service as an officer in Public Health Corps, he completed a residency in Neurology at Medical College of Georgia and a fellowship in Behavioral Neurology at University of Florida. Dr. Meador joined the faculty at Medical College of Georgia (1984-2002) where he became the Charbonnier Professor of Neurology. He was Chair of Neurology at Georgetown University (2002-2004) and joined the faculty of University of Florida in 2004. Dr. Meador has authored over 200 publications and serves on multiple journal editorial boards. His areas of research include cerebral lateralization, dementia, epilepsy, mechanisms of attention and memory, neglect syndrome, psychoimmunology, and the pharmacology and physiology of cognition.

Ruth E. Nemire is the director of community engagement and an associate professor of pharmacy practice at Nova Southeastern University College of Pharmacy (www.nova.edu) and a voluntary assistant professor for the University Of Miami College Of Medicine (www.med.miami.edu). She graduated from Ohio Northern University with a baccalaureate degree in pharmacy and completed a doctor of pharmacy degree from the University Of Toledo College Of Pharmacy. She completed her formal training at the University Of Miami College Of Medicine with a fellowship in Epilepsy/Neurology. After completing the baccalaureate degree in pharmacy from Ohio Northern Ruth worked as a clinical pharmacist for the State of Ohio in a developmental center focusing on treatment for psychiatric and neurological disorders. She then worked as an ambulatory care pharmacist for the Veteran’s Administration. She returned to the academy to complete a doctor of pharmacy degree from the University of Toledo and then completed a fellowship in neurology from the University of Miami. Following that she was appointed as the director of research at the Center for Neurology Studies, and assistant professor of neurology at Texas Tech Medical School in Lubbock, Texas. During her tenure in Texas she participated as a principle investigator in multiple drug trials for treatment of alzheimer’s, parkinson’s, migraine and epilepsy. She mentored and trained neurology residents in good clinical practices for research and pharmacy issues in patient care. She returned to Florida for an appointment as an assistant professor at the Nova Southeastern University College of Pharmacy in the Department of Pharmacy Practice. Nemire served as the director of clinical education for 7 years. In 2005 she took on the role of Director of Community Engagement for the College of Pharmacy. As the Director of Community Engagement Nemire works with various community organizations and schools to increase partnerships that benefit faculty, students and members of the community. She has authored chapters on preceptor development, and articles relating to service-learning, intellectual property, and course development and is the co-editor of the book Pharmacy Clerkships: A Survival Manual for Students (McGraw-Hill 2002). She is the co-developer of a web based experiential education program for NSU preceptors and students. She has served as chair of the NSU College of Pharmacy technology committee. She has served in multiple elected leadership positions nationally for the American Epilepsy Society (www.aesnet.org) and American Association of Colleges of Pharmacy (aacp.org). She has been asked to develop learning communities within the AACP organization during the 2005-2006 school year. She is currently completing a doctorate in education with a specialty in higher education leadership at Nova Southeastern University College of Education.

Chrysostomos P. Panayiotopoulos MD, PhD, FRCP is a renowned expert in the field of the epilepsies. He is now Consultant emeritus at St. Thomas’ hospital, London where he has served over the last 20 years as a Consultant in Clinical Neurophysiology and Epilepsies. Prior to this, he has been appointed Clinical Professor of Neurology, University of Colorado and Head and Professor of Neurology, University of Riyadh. He has also been an invited Associate Professor to Harvard University and Professor to the University of Western Australia. He has been one of the 12 members of the Task Force on Classification and Terminology of the International League Against Epilepsy.

CP Panayiotopoulos has investigated the clinical and neurophysiological aspects of muscle and peripheral nerve function (he was first to describe F-chronodispersion) and is particularly known for his study of the epilepsies.

CP Panayiotopoulos has written over 140 articles and editorials in prestigious journals including Brain, Neurology, Annals of Neurology, Archives of Disease in Childhood, Epilepsia, Journal of Child Neurology, Journal of Neurology, Neurosurgery and Psychiatry. He is the Editor of "The educational kit on epilepsies" and a member of the Editorial Board of Epilepsia, epilepsy.com, Epilepsy & Behavior, Epileptic Disorders, Medlink Neurology and serves as a reviewer for a number of journals including Lancet, Neurology, Epilepsia, and Epilepsy & Behavior.

His books on epilepsies and particularly "A clinical guide to epileptic syndromes and their treatment" 2nd edition, Springer, 2007 are praised as landmarks in the epileptological literature. His work on establishing the syndromic diagnosis of epilepsies and the appropriate video-EEG methodology for their diagnosis has been regarded as ground breaking. "Panayiotopoulos syndrome" and autonomic status epilepticus specific to childhood are amongst his main contributions. His publications on idiopathic generalized epilepsies and absence seizures have shaped the current thought of their diagnosis and management. He is also the first to establish objective differential criteria between visual symptoms of occipital epilepsy and migraine.

Steven Schachter, MD is Editor-in-Chief of epilepsy.com and a Vice President for medical information of the ETDP Executive Board and member of the Board of Directors and Scientific Advisory Board. Dr. Schachter is Professor of Neurology, Harvard Medical School; Director of Research Beth Israel Deaconess Medical Center Department of Neurology; Founding Editor and Editor-in-Chief, Epilepsy & Behavior, and a member of the Board of Directors of the Epilepsy Foundation.

Mark C. Spitz, MD. After receiving his medical degree from the University of Arizona College of Medicine in Tucson, Mark C. Spitz, MD, completed a 3-year residency in neurology at Baylor College of Medicine Affiliated Hospitals in Houston, Texas, and then a 2-year postdoctoral fellowship in clinical neurology and epilepsy at the Neurological Institute at the College of Physicians and Surgeons of Columbia University in New York City.

Since 1985, he has been affiliated with the University of Colorado Health Sciences Center, where he is currently professor in the Department of Neurology. Dr. Spitz is board certified in neurology and clinical neurophysiology and is a fellow of the American Academy of Neurology. He is a member of several professional and scientific societies, including the American Clinical Neurophysiology Society and the American Epilepsy Society and serves on the Technology Committee of the latter.

Dr. Spitz has received industry-sponsored grants to conduct drug treatment trials in different types of epilepsy. In 2003, he won the Commitment to Medical Excellence in Epilepsy Award from the Epilepsy Foundation of Colorado. He is an editor for Epilepsy.com , and has authored or coauthored 22 peer-reviewed publications, 52 abstracts, and 13 invited publications and book chapters largely concerning the diagnosis and treatment of various forms of epilepsy.

Dr. Weiner, is an Associate Professor of Neurosurgery and Pediatrics at NYU School of Medicine, and is the youngest faculty member in his Department to have received tenure at the medical school. As a pediatric neurosurgeon with particular expertise in the surgical treatment of childhood epilepsy, he also treats pediatric brain and spinal tumors, craniofacial disorders, pediatric spasticity, hydrocephalus, spina bifida, Chiari malformations, syringomyelia, and tethered spinal cord. He works closely with the NYU Comprehensive Epilepsy Center as the pediatric epilepsy surgeon for the center. As a result, Dr. Weiner has developed one of the largest modern experiences in the surgical treatment of young children with medically refractory epilepsy, with a national and international referral base. Dr. Weiner has helped pioneer a novel epilepsy surgery approach in the treatment of children with Tuberous Sclerosis, work that has resulted in several publications as well as invited lectures at several international meetings. In the laboratory, he is studying brain development and, specifically, the role of the Sonic Hedgehog signaling pathway in formation of a childhood brain tumor, medulloblastoma. His work is funded by an NIH research grant. He has approximately 60 publications to date. He completed his neurosurgical training at NYU under Dr. Patrick Kelly, Chairman, and then completed a fellowship in Pediatric Neurosurgery at NYU. In addition, he was named the recipient of the 1996 Van Wagenen Fellowship by the AANS, the “Rhodes Scholarship” of neurosurgery, and the premier award granted to a graduating neurosurgery resident. Like Dr. Kelly, the 1976 Van Wagenen Fellow, Dr. Weiner chose to spend his fellowship in Paris, where he worked in the laboratory of Professor Nicole Le Douarin studying the biology of brain development. Dr. Weiner received his B.A. from the University of Pennsylvania, graduating Summa Cum Laude, Phi Beta Kappa in his junior year, and was one of three graduating seniors who received the Dean's Scholar Award for highest academic standing in his class. Dr. Weiner earned his M.D. from Cornell, where he received the John Metcalf Polk Prize for graduating with highest academic standing in his class, as well as Alpha Omega Alpha in his junior year.

Dr. Wheless is Professor and Chief of Pediatric Neurology and the Le Bonheur Chair in Pediatric Neurology at the University of Tennessee Health Science Center in Memphis. He also serves as Director of the Neuroscience Institute and the Le Bonheur Comprehensive Epilepsy Program for the Le Bonheur Children’s Medical Center. He is Clinical Director and Chief of Pediatric Neurology at St. Jude Children’s Research Hospital.

Dr. Wheless is a Diplomat of the American Board of Pediatrics, and the American Board of Psychiatry and Neurology with special qualifications in Child Neurology and in Clinical Neurophysiology. He is a fellow of the American Academy of Pediatrics. Dr. Wheless is a member of the Editorial Board of Journal of Child Neurology, Formulary, and Epilepsy.com and serves as reviewer of a number of journals including Neurology, Epilepsia, Pediatrics, and Epilepsy and Behavior. Dr. Wheless’s primary interests include child convulsive disorders. His research is focused on pediatric anti-epileptic drug development, the ketogenic diet, epilepsy surgery, and magnetoencephalography. Dr. Wheless is the author of more than 200 chapters, articles and abstracts on these subjects. He has lectured widely on pediatric epilepsy. He received his medical degree from the University of Oklahoma and completed residency training in pediatrics at the University of Oklahoma and then pediatric neurology at Northwestern University in Chicago at Children’s Memorial Hospital. His EEG/clinical epilepsy training was at the Medical College of Georgia in Augusta.